Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Sort by:
Frontier Pharma: Antibacterial Therapeutics - High levels of Pipeline Innovation Focused on the Increasing Unmet Need Associated with Antibiotic Resistance

Published: Jan-2018

Antibacterial resistance is currently believed to be responsible for over 700,000 deaths each year. As antibiotic resistance.....

$6995
More Info
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis

Published: Jan-2018

GBI Research’s latest report: “Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect.....

$2995
More Info
Frontier Pharma: Transplantation Therapeutics - A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation

Published: Dec-2017

In 2015 a total of 127,000 transplantations were performed worldwide, an increase of 5.8% from 2014, with 33,000 of these.....

$6995
More Info
COPD Therapeutics in Asia-Pacific Markets to 2023 – Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies

Published: Dec-2017

Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by.....

$4995
More Info
Global Genetic Disorders Drugs Market to 2023 – A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease

Published: Dec-2017

The genetic disorders therapy area consists of indications that arise because of an abnormality in a person’s DNA......

$4995
More Info
Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 – Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market

Published: Dec-2017

Head and neck cancer (HNC) is the sixth most common cancer, and its incidence is growing. The annual incidence of HNCs.....

$4995
More Info
Global Cardiovascular Disease Drugs Market to 2023 – Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

Published: Dec-2017

The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart.....

$4995
More Info
Lower Female Reproductive System Cancers Drug Development Pipeline Review, 2017

Published: Dec-2017

This report provides an overview of the Lower Female Reproductive System Cancers pipeline landscape. The report provides.....

$3995
More Info
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

Published: Dec-2017

This report provides an overview of the bladder and ureter pipeline landscape. The report provides comprehensive information.....

$3995
More Info
Frontier Pharma: Neurodegenerative Diseases – Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PD

Published: Nov-2017

Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area.....

$6995
More Info
Sort by: